Arrowhead Pharmaceuticals Reports Fiscal 2024 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq set for lower open as AI stocks slide on debt concerns
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent oil slips as US weighs easing sanctions on Russia's 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 58.51 +0.14 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.37 | 52 Week High | $8.22 | |||
| Open | $58.50 | 52 Week Low | $3.07 | |||
| Day High | $59.40 | P/E | N/A | |||
| Day Low | $58.02 | EPS | $-1.30 | |||
| Volume | 203,429 | |||||
